临床研究: 各种ER / PR / HER2和肿瘤等级分类的乳腺癌5年生存率

临床研究: 各种ER / PR / HER2和肿瘤等级分类的乳腺癌5年生存率

Clinical Study：

Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers

By Carol A. Parise and Vincent Caggiano

From Journal of Cancer Epidemiology

Volume 2014, Article ID 469251, 11 pages 详见
1.https://www.hindawi.com/journals/jce/2014/469251/fig1/

2. http://dx.doi.org/10.1155/2014/469251